scispace - formally typeset
T

Tomohiko Ogawa

Researcher at Asahi University

Publications -  118
Citations -  13431

Tomohiko Ogawa is an academic researcher from Asahi University. The author has contributed to research in topics: Porphyromonas gingivalis & Lipid A. The author has an hindex of 41, co-authored 118 publications receiving 13057 citations. Previous affiliations of Tomohiko Ogawa include Osaka University.

Papers
More filters
Patent

Dioxins analyzing method

TL;DR: In this paper, the authors proposed a method to analyze dioxins accumulated in the bodies of animals by detecting a specimen more easily sampled than blood and analyzed with the approximately same accuracy as a blood specimen and using dioxin contained in the specimen as an index.
Journal ArticleDOI

Immunobiological activities of sodium dodecylsulfatesoluble fractions derived from the cell envelopes of oral gram-negative, anaerobic rods

TL;DR: In this article, the chemical composition and immunobiological activities of sodium dodecylsulfate (SDS)soluble fractions of cell envelopes derived from gram-negative, anaerobic rods (A. actinomyceterncomitans ATCC 29522, A. gingivalis #381, #1021, B. asaccharolyticus ATCC 27067 and F. nucleatum ATCC 25586) were investigated.
Patent

Peptides containing sequence of porphyromonas gingivalis type ii pilus protein and their uses

TL;DR: In this article, peptides corresponding to a fragment derived from an amino acid sequence of 72KDa subunit protein constituting type II pilus of Porphyromonas gingivalis and comprising a fragment containing continuing 5-10C amino acid residues expressed by formulas I to III, etc.
Journal ArticleDOI

Research articleImmunochemical characterisation and epitope mapping of a novel fimbrial protein (Pg-II fimbria) of Porphyromonas gingivalis

TL;DR: Mouse monoclonal antibody specific for a 72-kDa major cell-surface protein derived from Porphyromonas gingivalis OMZ 409 reacted with 72K-CSP but not with 41-k da fimbrial subunit protein (41K-fimbrilin) derived from P. gingialis 381, which suggested that P.g-II fimbrian protein molecule definitely reacted with the serum of patients with periodontal diseases.
Patent

Helicobacter pylori lipid a

TL;DR: In this article, a new Helicobacter pylori lipid A having a specific chemical structure, low in toxicity and low in pyrogenicity, and useful for immunostimulators, infectious disease medicines, antitumor medicines, antiviral medicines, etc., as a new immunologically active substance.